Advancing adeno-associated virus (AAV) gene therapy for Duchenne muscular dystrophy
A human skeletal muscle xenograft model is adapted, using 222 transplanted muscles from human donors, to use as a platform for AAV delivery and shows for the first time, that human muscles transplanted in immune-deficient mice are efficiently transduced by AAV vectors at following intravenous injection of the host mice...